Published on | 3 months ago
Programmes ERCThe results of the 2024 European Research Council (ERC) Proof of Concept (PoC) Grant call (2nd deadline date 17 September 2024) were published. Principal Investigators (PIs) with a main ERC Grant that is ongoing or ended after 1 January 2023 are eligible to participate in an ERC 2024 PoC Grant. The ERC PoC Grants aim at facilitating exploration of the commercial and social innovation potential of ERC funded research and are therefore available only to PIs whose proposals draw substantially on their ERC funded research.
For this call in total 134 ERC PoC Grants were awarded to PIs working in 20 different countries across Europe. In the ERCEA news articles more background on the evaluation results and several project examples are highlighted. Among the 134 selected researchers are at least nine based at Flemish host institutions. The projects of several PIs are presented in the news articles of Universiteit Gent and VIB.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
Digital, Industry & Space Climate, Energy, Mobility Agro-Food, Environment
The Clean Industrial Deal is described as "a bold business plan to support the competitiveness and resilience of our industry." It aims to boost production in green industries, with special focus on energy-intensive industries - vital for European material production and decarbonization goals. 6 main elements The Deal presents measures to boost e... read more
Security Digital, Industry & Space Digital Europe
In Digital Europe, knowledge of the underlying EU policies and legislations is a key element when drafting a proposal, as they play an important role in the “relevance” evaluation criterion. Also for Horizon Europe Cluster 3 (Cybersecurity) and Cluster 4 (Digital), this knowledge can be handy for applicants. To support... read more
The METHYLOMIC project, ‘targeting hope for personalised medicine in immune-mediated inflammatory diseases’ obtained funding from Horizon Europe’s Health Cluster. The project aims to personalise treatment allocation and enhance the effectiveness of medications for chronic immune-mediated diseases such as Crohn’s disease, rheumatoid arthritis, and psoriasis. BIRD, the Belgian inflammatory bowel disease research and development group, is a partner in the project and is involved in the OmiCrohn trial, a prospective randomised clinical trial for individualised therapy in Crohn’s disease patients. With BIRD’s active role in this trial, the project is set to deliver predictive, biomarker-based therapies that bring renewed hope for Crohn’s disease patients across Europe.